1062725

Tsao-Wei Liang — FEI 3014554662

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 10, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Philadelphia, PA (United States)

Additional Details

Clinical Investigator (CI)